Endopthalmitis

Reading File
Finding Sources
Searching PubMed

endophthalmitis treatment outcomes

Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Loading Image
I now have comprehensive information to deliver a detailed, well-structured answer on endophthalmitis. Let me compile it.

Endophthalmitis

Endophthalmitis is a severe, sight-threatening inflammation of the intraocular contents (vitreous and aqueous humors), almost always caused by infection. It is one of the most feared complications in ophthalmology and requires immediate diagnosis and treatment.

Classification

TypeSourceCommon setting
Exogenous (>80%)External inoculationPost-surgical, post-traumatic, keratitis-associated
Endogenous (<20%)Hematogenous seedingSepsis, IV drug use, immunocompromise
Exogenous subtypes include:
  • Acute postoperative (after cataract surgery, most common)
  • Delayed/subacute postoperative
  • Bleb-related (post-trabeculectomy)
  • Post-traumatic (including retained IOFB)

Postoperative Endophthalmitis (Most Common Form)

Incidence & Pathogenesis

The contemporary incidence after cataract surgery is approximately 0.1%. Bacterial toxins and the host's own inflammatory response cause rapid, irreversible photoreceptor damage -- effects can continue long after the eye is sterilized.
Risk factors:
  • Posterior capsule rupture
  • Prolonged procedure time / combined surgery (e.g. with vitrectomy)
  • Clear corneal sutureless incision, temporal incision
  • Wound leak on the first postoperative day
  • Adnexal disease (blepharitis, dacryocystitis), diabetes
  • Topical anaesthesia

Clinical Features

Symptoms: Sudden onset pain, redness, and visual loss (typically days 2-7 after surgery).
Signs (vary with severity):
  • Eyelid swelling, chemosis, conjunctival injection, discharge
  • Relative afferent pupillary defect (common)
  • Corneal haze
  • Fibrinous exudate and hypopyon (hallmark sign)
  • Vitritis with impaired fundal view
  • Loss of red reflex
  • Severe vitreous debris (see below)
Postoperative endophthalmitis with hypopyon
Clinical photo: Postoperative endophthalmitis showing hypopyon (Wills Eye Manual)

Causative Organisms

Acute Postcataract

OrganismNotes
S. epidermidis (most common)Gram-positive; reasonable prognosis with early treatment
S. aureusMore virulent
Streptococcal speciesOften severe; poor prognosis
Gram-negatives (Pseudomonas, Klebsiella, Proteus, E. coli, etc.)~10% of isolates
Bacillus cereusVery virulent; post-traumatic
Overall: ~90% Gram-positive, ~10% Gram-negative isolates.
Other settings:
  • Bleb-associated: Streptococcus or Gram-negatives (more virulent than post-cataract)
  • Post-intravitreal injection: S. epidermidis and oral flora (notably Streptococcus)
  • Post-traumatic: Staphylococcus spp. and Bacillus spp. (~90% of culture-positive cases)
  • Subacute/delayed: Cutibacterium acnes (formerly Propionibacterium acnes), fungi

Differential Diagnosis

  • TASS (Toxic Anterior Segment Syndrome): Occurs 6-24 hours post-cataract; diffuse corneal edema with KP; sterile, due to endotoxin on instruments. Responds to steroids.
  • Acute noninfectious uveitis flare (HLA-B27 associated)
  • Sterile endophthalmitis (e.g. after intravitreal triamcinolone or anti-VEGF)
  • Retained lens particle uveitis
  • Vitreous hemorrhage (especially depigmented blood)
Rule of thumb: If any doubt exists, treat as infectious endophthalmitis -- early recognition leads to better outcomes.

Management

Step 1: Sample First

Immediately obtain:
  • Aqueous tap: 0.1-0.2 mL via limbal paracentesis (25G needle on tuberculin syringe)
  • Vitreous tap: More likely to yield positive culture; 0.2-0.4 mL from mid-vitreous at 3.5 mm from limbus in a pseudophakic eye; use a disposable vitrector if available
  • B-scan ultrasound before sampling if no clinical view (to exclude retinal detachment)
Send for: Gram stain, Giemsa, methenamine silver, and cultures (blood agar, chocolate agar, Sabouraud, thioglycolate, anaerobic). Use PCR if cultures are negative.
Note: C. acnes requires anaerobic culture held for 14 days - it will be missed otherwise.

Step 2: Intravitreal Antibiotics (Cornerstone of Treatment)

Injected immediately after sampling, into the mid-vitreous cavity via 25G needle:
DrugDoseCoverage
Vancomycin2 mg in 0.1 mL (saline only)Gram-positives including MRSA
Ceftazidime2 mg in 0.1 mLGram-negatives including Pseudomonas
Amikacin0.4 mg in 0.1 mLAlternative to ceftazidime if definite penicillin/cephalosporin allergy - HIGHER retinal toxicity risk
Intravitreal vancomycin used routinely as prophylaxis has been associated with haemorrhagic occlusive retinal vasculitis and should be avoided in prophylaxis.

Step 3: Adjuncts

  • Oral fluoroquinolone: Moxifloxacin 400 mg/day x 10 days (excellent ocular penetration)
  • Topical antibiotics: Vancomycin 5% or ceftazidime 5%, 4-6x daily (limited benefit, mainly to protect wounds)
  • Subconjunctival antibiotics: Vancomycin 50 mg + ceftazidime 125 mg (doubtful additional benefit when intravitreal given)
  • Topical steroids: Dexamethasone 0.1% 2-hourly; start after 48 hours (once fungal infection excluded)
  • Topical mydriatic: Atropine 1% twice daily
  • Oral steroids: Prednisolone 1 mg/kg/day in severe cases after 12-24 hours (fungal infection excluded); The EVS protocol used prednisone 60 mg/day x 5 days

Step 4: Pars Plana Vitrectomy (PPV)

The landmark Endophthalmitis Vitrectomy Study (EVS) established:
  • Immediate PPV is indicated when VA = light perception only -- 50% reduction in severe visual loss
  • Eyes with VA of hand movements or better do NOT benefit from immediate PPV over tap-and-inject alone
  • EVS conclusions apply to post-cataract surgery; cannot be extrapolated to all forms

Step 5: Follow-up at 48 hours

  • Relief of pain is a useful early sign of response
  • Look for contraction of fibrinous exudate and reduction of hypopyon
  • If worsening: review sensitivities, modify antibiotics, consider PPV if not yet done, repeat intravitreal antibiotics
  • Avoid repeated amikacin (retinal toxicity risk)

Delayed-Onset (Subacute) Postoperative Endophthalmitis

  • Onset: Weeks to months after surgery
  • Classic organism: Cutibacterium acnes -- presents as recurrent anterior uveitis, granulomatous KP, white lens capsular plaque, minimal injection/pain, only transient response to steroids
  • Other organisms: Fungi (Aspergillus, Candida, Cephalosporium), S. epidermidis
  • Treatment: Similar initial approach; if C. acnes, may require removal of IOL and capsular remnants; if fungal, intravitreal amphotericin B (5-10 μg/0.1 mL) or voriconazole (100 μg/0.1 mL)

Bleb-Related Endophthalmitis (Post-Trabeculectomy)

  • Organisms are significantly more virulent than post-cataract (streptococcal, Gram-negatives)
  • Symptoms far more severe than blebitis
  • Signs: White milky bleb, severe injection, large hypopyon, vitreous involvement, loss of red reflex
  • Treatment: Vitreous + aqueous samples immediately; ceftazidime 2 mg + vancomycin 2 mg intravitreal; repeat at 48h; consider posterior vitrectomy; oral fluoroquinolones x 10-14 days; topical steroids after 48h

Post-Traumatic Endophthalmitis

  • Risk in ~1/10 penetrating trauma cases with retained IOFB
  • Prophylactic antibiotics (ciprofloxacin 750 mg twice daily or moxifloxacin 400 mg once daily) for open globe injuries
  • Prompt IOFB removal is paramount
  • Prophylactic intravitreal antibiotics for high-risk cases (agricultural injuries)

Endogenous Endophthalmitis

  • Hematogenous seeding in patients with sepsis, IV drug use, immunosuppression, or indwelling catheters
  • Klebsiella pneumoniae associated with liver abscess is the leading cause of endogenous bacterial endophthalmitis (especially in Asia)
  • Fungal endogenous: almost exclusively Candida spp. (yeasts); Aspergillus also occurs
  • Treatment: systemic antibiotics targeting the primary source + intravitreal antibiotics

Prognosis

Outcome depends on duration of infection before treatment and organism virulence:
ScenarioVisual outcome
VA = light perception at presentation~30% achieve 6/12 after treatment
VA = better than LP at presentation~60% achieve 6/12
Bacillus cereus infection70% achieve ≤6/60 (exotoxin-mediated retinopathy)
Streptococcal infection55% achieve ≤6/60
Late complications: Epiretinal membrane, cystoid macular edema, retinal ischemia, hypotony, retinal detachment, secondary glaucoma, phthisis bulbi.

Prophylaxis (Cataract Surgery)

  • 5% povidone-iodine in conjunctival fornices for ≥3 minutes before surgery (strongest evidence)
  • Intracameral cefuroxime 1 mg/0.1 mL at end of surgery (first choice)
  • Intracameral moxifloxacin 0.5 mg/0.1 mL if cefuroxime unavailable
  • Treatment of pre-existing blepharitis, dacryocystitis, conjunctivitis
  • Early resuturing of leaking wounds
  • Avoid intracameral vancomycin as routine prophylaxis (risk of HORV)

Sources:
  • Kanski's Clinical Ophthalmology: A Systematic Approach, 10th ed., Ch. 10-11 (Acute & Delayed Postoperative Endophthalmitis; Bleb-Related & Post-Traumatic Endophthalmitis)
  • The Wills Eye Manual, 8th ed., §12.13 (Postoperative Endophthalmitis)
  • Tietz Textbook of Laboratory Medicine, 7th ed. (Eye Infections; Endophthalmitis)
  • Robbins, Cotran & Kumar Pathologic Basis of Disease (Endophthalmitis)
  • Recent meta-analysis (PMID: 39167582): Visual outcomes by organism in post-intravitreal injection and post-cataract endophthalmitis (2024, Retina)
This is a shared conversation. Sign in to Orris to start your own chat.